stoxline Quote Chart Rank Option Currency Glossary
  
Frequency Therapeutics, Inc. (FREQ)
0.2996  0.014 (4.76%)    11-03 16:00
Open: 0.29
High: 0.32
Volume: 309,164
  
Pre. Close: 0.286
Low: 0.28
Market Cap: 11(M)
Technical analysis
2023-11-17 4:50:12 PM
Short term     
Mid term     
Targets 6-month :  0.48 1-year :  0.56
Resists First :  0.41 Second :  0.48
Pivot price 0.25
Supports First :  0.27 Second :  0.18
MAs MA(5) :  0.25 MA(20) :  0.26
MA(100) :  0.42 MA(250) :  1.15
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  61.2 D(3) :  46.5
RSI RSI(14): 51.6
52-week High :  5.59 Low :  0.18
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ FREQ ] has closed below upper band by 7.1%. Bollinger Bands are 51.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.32 - 0.32 0.32 - 0.32
Low: 0.28 - 0.28 0.28 - 0.28
Close: 0.3 - 0.3 0.3 - 0.3
Company Description

Headline News

Mon, 06 Nov 2023
Frequency Therapeutics Inc (FREQ) Announces Merger and Private Placement of $117 Million - Yahoo Finance

Fri, 03 Nov 2023
Korro Bio and Frequency Therapeutics Merge - citybiz

Tue, 18 Jul 2023
With Korro Bio merger in works, Frequency stops program for MS |... - Multiple Sclerosis News Today

Mon, 17 Jul 2023
Frequency (FREQ) Up 77% on Merger Deal With Korro Bio - Nasdaq

Fri, 14 Jul 2023
Korro Bio and Frequency Therapeutics to Merge - citybiz

Fri, 14 Jul 2023
Why Are Frequency Therapeutics Shares Surging Today - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Industry:
Shares Out 37 (M)
Shares Float 35 (M)
Held by Insiders 7.2 (%)
Held by Institutions 14.1 (%)
Shares Short 366 (K)
Shares Short P.Month 515 (K)
Stock Financials
EPS -1.9
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -42.5 %
Return on Equity (ttm) -100 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) -1.16
Sales Per Share 0
EBITDA (p.s.) -1.63
Qtrly Earnings Growth 0 %
Operating Cash Flow -43 (M)
Levered Free Cash Flow -18 (M)
Stock Valuations
PE Ratio -0.16
PEG Ratio 0
Price to Book value 0.29
Price to Sales 0
Price to Cash Flow -0.26
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android